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Review question/objective 
The aim of this systematic review is to comprehensively search the available literature and to 
summarize the best available evidence from systematic reviews in relation to published screening 
tools to identify pre-frailty and frailty in older adults, that is: (i) to determine their psychometric 
proprieties; (ii) to assess their capacity to detect pre-frail and frail conditions against established 
methods; and (iii) to evaluate their predictive ability. 
More specifically, the review will focus on the following questions: 
 What is the reliability and validity of existing screening tools that assess pre-frailty/frailty in older 
patients? 
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 How sensitive and specific are pre-frailty/frailty assessment tools in identifying patients with poor 
prognosis? 
 What is the ability of available pre-frailty/frailty assessment tools to predict adverse health 
outcomes such as functional disability, hospitalization, institutionalization, comorbidities and 
death? 
Background 
Frailty is an age-related state of vulnerability resulting from a balance between the  maintenance of 
health and the deficits threatening it.
1,2 
This clinical condition compromises the ability to cope with 
daily or acute stressors and, further, increases the risk of adverse outcomes, predisposing those 
involved to disability and dependency on others for daily life activities, and leading to hospitalization 
and institutional placement.
3,4
 It is also a predictor of higher mortality rates.
4-7
 In the absence of 
biological markers, an operational definition of frailty has been proposed.
2,8 
This definition is based on 
physical markers, including weakness with low muscle strength (e.g. poor grip strength), overall 
slowness (particularly of gait), decreased balance and mobility, fatigability or exhaustion, low physical 
activity and involuntary weight loss. For diagnostic purposes, at least three of these symptoms must 
be observed.
8
 The presence of only one or two of them indicates the earlier stage of frailty, namely, 
pre-frailty. Despite high predictive validity of this operational definition, and despite its common use in 
clinical settings, many researchers believe it is insufficient, asserting that it should also include 
cognitive and mental health domains, and possibly also social domains such as living alone.
9-12 
Other 
dimensions recognized as important for identifying frailty are the ability to deal with activities of daily 
living and quality of life, as for individuals with this clinical condition both of these areas tend to be 
decreased.
9,13
 
This lack of consensus on the definition of frailty (based on physical markers as opposed to a broader 
multidimensional approach) is also reflected in divergences related to the prevalence data obtained 
from epidemiological studies. Systematic comparison of these data
14
 shows that frailty prevalence 
differs from 4% to 17% in the population aged 65 and over, and in case of pre-frailty, prevalence 
varies from 19% to 53% of the same age group, with average values of 10.7% and 41.6%, 
respectively. The divergences between estimates are also conditioned by demographic variables 
such as age and gender. Namely, for elders aged 80-84 the prevalence of frailty is estimated as 
15.7%, and for elders over the age of 84, 26.1%. Additionally, women tend to have higher rates of 
frailty than men. 
Although the condition of frailty has been studied for years, there is no consensus on its 
pathophysiologic mechanism. According to some authors
2,8,15
, this state of increased vulnerability is 
due to accumulation of subthreshold decrements in physiologic reserves that affects multiple 
physiologic systems.
 
Other authors
16,17 
have described frailty in terms of progressive dysregulation in 
a number of main physiologic systems and their complex interconnected network, and subsequent 
depletion of homeostatic reserve and resiliency. Recently, discussion on the psychopathological 
mechanism of this clinical condition has been enriched by new theoretical proposals associating frailty 
to reduced capacity to compensate ageing-related molecular and cellular damage.
13,18 
In all these 
approaches it is assumed that the development of frailty may be modulated by disease. In other 
words, it can be precipitated or exacerbated by the occurrence of comorbid pathological conditions.
19-
21 
It is also suggested that increased vulnerability for adverse health outcomes can precede the onset 
of chronic diseases.
19,20
 However, according to Bergman et al
19
, it is probable that in this case, frailty 
is just a manifestation of subclinical and undiagnosed stages of such diseases. 
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Because of the high prevalence and the severity of adverse outcomes of frailty, its screening should 
be a priority in appropriate components of primary care networks (including general practice, 
geriatrics, psychology, etc.), as well as in institutional or community care settings. Early diagnosis of 
this clinical condition can help improve care for older adults, making possible the minimization of the 
risk of pre-frail states developing into frail states (primary prevention), and implementation of 
therapeutic measures in order to attenuate or delay underlying conditions and symptoms, or to 
ameliorate the impact on independence or healthy and engaged lifestyles (loss of which would in turn 
have a further impact on frailty development, i.e. secondary  prevention).
2,4
 In more advanced stages, 
frailty assessment provides valuable data necessary to plan and implement intervention strategies 
oriented to the preservation of functional status or to control the progression of adverse outcomes, 
such as recurrent hospitalizations, institutionalization or death (tertiary prevention).
2,4
 The evidence 
obtained from the implementation of various types of interventions for frailty indicates that the frailty 
condition can be managed and reduced.
22-25
 Screening for frailty can also provide information on 
populations at high risk of disability and poor prognosis, and help to identify reversible risk factors.
2
 
These data are especially important for determining variables that make specific interventions more 
beneficial to specific patients. 
In order to identify individuals at risk of frailty, several assessment tools have been developed. The 
most widely cited focus on physical markers of frailty
2,8
 or are based on the accumulation of deficits 
from physical, cognitive, mental health and functional domains.
13,26
 However, both types of measures 
seem to be insufficient. The first one does not cover all dimensions of frailty and consequently does 
not provide indications useful to treatment choice and care planning, and the last one is time 
consuming and thus is difficult to integrate into day-to-day health care practice.
27 
In more recent 
approaches, the indices created for frailty assessment integrate demographic, medical, social and 
functional information, and demonstrate their usefulness either for diagnostic purposes or to predict 
adverse health outcomes.
28
 According to the literature, there are more than 20 different measures 
being used for frailty screening. Nonetheless, it is still unknown how their characteristics match 
different samples within the frail/pre-frail condition and robust populations, and what is the best fit 
between these measures, purposes (e.g. to predict need for care, mortality or potential response to 
intervention) and contexts/populations to assess frailty in older age. Also, the reliability and validity of 
these measures need to be clarified, as well as the comparative sensitivity and specificity in 
identifying patients at risk of a poor prognosis. 
A scoping search identified a large number of relevant systematic reviews; however in most cases 
they are confined to specific assessment measures related to a specific clinical model (phenotype 
model
8
, cumulative deficits model
13
 and predictive model
28
). For a clear view and objective evaluation 
of existing tools, this set of evidence needs to be systematized, compared and synthesized. In other 
words, it is essential to conduct an umbrella review. 
A preliminary search of the JBI Database of Systematic Reviews and Implementation Reports, the 
Cochrane Database of Systematic Reviews, Prospero, CINAHL and Medline has revealed that there 
is currently no overview of reviews or umbrella review (neither published nor in progress) on this topic 
of sufficient reliability, validity and capacity to detect pre-frail and frail conditions, and with predictive 
accuracy of available screening tools for frailty in older adults
29
 
The main goal of this umbrella review is to consolidate the available evidence regarding screening for 
pre-frailty and frailty from the published literature. More specifically, reviews will be summarized in 
order to determine the quality of screening tools in terms of frailty diagnosis and frailty prognosis.  
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Inclusion criteria  
Types of participants 
This umbrella review will consider systematic reviews that include older adults (male and female), 
aged 65 years or over, in primary care networks (general practice, geriatrics, psychology, etc.) and in 
institutionalized or community care settings.   
Because of the aims of this review (to determine the utility of screening in terms of detecting or 
predicting risk of currently available tools that assess pre-frailty and frailty in older adults in terms of 
outcome prognostics), various definitions of frailty will be considered: (i) focused on physical markers 
of frailty
2,8
, (ii) based on the accumulation of deficits  from physical, cognitive, mental health and 
functional domains
13,26
, and (iii) integrating demographic, medical, psychological, social and functional 
information.
28
  
Interventions 
The focus of this umbrella review will be systematic reviews that have evaluated the reliability and 
validity of available screening tools for pre-frailty and frailty in older adults, and that have assessed 
the utility of these tools to detect or predict risk for the onset/development of frailty or for other 
adverse events.  
The capacity to detect pre-frail and frail conditions and predictive accuracy of the index tests will be 
compared against reference tests from the Cardiovascular Health Study (CHS) phenotype model
8
 and 
the Canadian Study of Health and Aging (CSHA) cumulative deficit model
13
 or other recognized gold 
standards (example, Comprehensive Geriatric Assessment [CGA]
30
).   
Types of outcomes 
This umbrella review will consider reviews that include the following outcome measures: 
(i) Reliability of frailty screening tools defined in terms of internal consistency and repeatability (test- 
retest) of findings. 
(ii) Criterion validity of frailty screening tools defined as a measure of how well one variable or set of 
variables predicts an outcome based on information from other variables, as well as construct 
validity defined as the degree to which a test measures what it claims or purports to measure. 
(iii) Sensitivity and specificity determined by comparison with the reference test (CHS, CSHA or 
CGA). Also, positive predictive values (PPV), negative predictive values (NPV) and likelihood 
ratios (LRs) will be considered.  
(iv) Predictive accuracy of frailty screening tools for risks of adverse health outcomes, including 
functional disability, hospitalization, institutionalization, comorbidities and death.  
Types of studies 
This umbrella review will consider quantitative systematic reviews, meta-analyses and pooled 
analyses identifying relevant scientific evidence related to the reliability, validity and capacity to detect 
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pre-frail and frail conditions, and the predictive accuracy of available screening tools for frailty in older 
adults. 
Search strategy 
The search strategy will aim to find published systematic reviews and meta-analyses. A three-step 
search strategy will be utilized in this umbrella review. An initial limited search of MEDLINE and 
CINAHL will be undertaken followed by an analysis of the text words contained in the title and 
abstract, and of the index terms used to describe the articles. A second search using all identified 
keywords and index terms will then be undertaken across all included databases. Thirdly, the 
reference list of all identified reports and articles will be searched for additional studies. Studies 
published in English from 2001 will be considered for inclusion in this review as 2001 was the year of 
publication of Fried’s
8
 paper that was shown to be seminal for research on frailty condition. 
Studies in other languages or outside the timeframe selected will be excluded. 
The databases to be searched include: 
MedicLatina, CINAHL Complete, MEDLINE via EBSCOhost Web, Scielo – Scientific Electronic Library 
Online, Cochrane Database of Systematic Reviews (CDSR), Centre for Reviews and Dissemination 
Databases (Database of Reviews of Effects [DARE]), PROSPERO register and Joanna Briggs 
Institute (JBI) Library of Systematic Reviews and Implementation Reports. 
The search for unpublished studies will include:  
Grey Literature Report (The New York Academy of Medicine), ProQuest – Nursing and Allied Health 
Source Dissertations. 
Initial keywords to be used will be: 
review, meta-analysis, pre-frailty, frailty, diagnostic test, assessment, accuracy, clinical risk 
stratification instruments, screening, sensitivity, specificity, reliability validity, positive predictive value 
and negative predictive value. 
Papers will be assessed for relevance utilizing the title, abstract and index terms, including papers 
found from searching reference lists of relevant papers. Screening will be conducted independently by 
two reviewers. 
Assessment of methodological quality 
Papers selected for retrieval will be assessed by two independent reviewers for methodological 
validity prior to inclusion in the review using standardized critical appraisal instruments from the 
Joanna Briggs Institute System for the Unified Management, Assessment and Review Instrument 
(JBI-SUMARI) and the Joanna Briggs Institute Reviewers’ Manual 2014
29
 (Appendix I). Any 
disagreements that arise between the reviewers will be resolved through discussion, or with a third 
reviewer. 
Data extraction 
Data will be extracted from papers included in the review independently by two reviewers, using the 
standardized data extraction tool from the JBI instrument designed for umbrella reviews (Appendix II). 
Data extracted will include specific details about type of review (i.e. meta-analysis – sensitivity, 
specificity, true positives [TP], false positives [FP], true negatives [TN] and false negatives [FN] are 
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taken directly from the source papers or narrative summary), countries where the studies were 
conducted, number of studies in the review, instrument references, participants (number, age group), 
outcomes identified (type/characteristics), length and completeness of follow-up, primary outcome 
measures and specific objectives. For missing information or to clarify unclear data, the authors of this 
umbrella review will endeavor to contact the author(s) of the paper in question to seek clarification. 
Any disagreements that arise between the reviewers will be resolved through discussion, or with a 
third reviewer.  
Data summary  
There may be an overlap of included studies in the identified systematic reviews, which will be 
apparent on full text examination. When this occurs, the frequency of overlap of studies will be noted. 
Data extracted from selected reviews related to the identified quality of screening tools (specified in 
Types of outcomes section) will be tabulated and accompanied by a narrative to address the review 
questions in line with the inclusion criteria. All results will be subject to double data entry. Tabular 
presentation of quantitative results describing the reliability, validity, capacity to detect pre-frail and 
frail conditions, and the predictive accuracy of available screening tools will be presented with 
supporting interpretation. Tables will include a high level of detail for each included systematic review, 
including: instrument references, number of studies, total number of participants, heterogeneity of 
results, setting, age and co-morbidity.
29
 
The results of the review will be provided in tabular format in a “Summary of Evidence” table that 
consists of instrument references and estimates included in the systematic review(s). The criteria that 
will be evaluated include methodological limitations, consistency, risk of bias and relevance to the 
study population.
29
 
It is also important to note that the reviewers are planning to undertake conversion of data where 
possible to facilitate further analysis. Positive and negative likelihood ratios, odds ratios and 95% 
confidence intervals will be recalculated. The data will be displayed on forest and summary receiver 
operating characteristic (ROC) plots. Heterogeneity will be assessed statistically using the standard 
Chi-square and also explored using subgroup analyses based on the different study designs included 
in this review. To perform additional analysis and plots, the Stata Statistical Software (version 11.1. 
College Station, TX: StataCorp LP) will be used.  
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Appendix I: Appraisal instruments 
JBI critical appraisal checklist for systematic reviews and research syntheses 
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Appendix II: Data extraction instruments 
JBI data extraction form for review for systematic reviews and research syntheses 
 
 
 
